Gene · 187
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cross-species transcriptomics reveals bifurcation point during the arterial-to-hemogenic transition. | Commun Biol | 2023 | 37558796 | PubTator, text mining | PubMed |
| APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion: Retraction. | Anticancer Drugs | 2023 | 37555813 | PubTator, text mining | PubMed |
| ELABELA/APJ Axis Prevents Diabetic Glomerular Endothelial Injury by Regulating AMPK/NLRP3 Pathway. | Inflammation | 2023 | 37540330 | PubTator, text mining | PubMed |
| APLNR marks a cardiac progenitor derived with human induced pluripotent stem cells. | Heliyon | 2023 | 37539315 | PubTator, text mining | PubMed |
| Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs. | Front Pharmacol | 2023 | 37521478 | PubTator, text mining | PubMed |
| Modulation of the Host Response as a Therapeutic Strategy in Severe Lung Infections. | Viruses | 2023 | 37515150 | PubTator, text mining | PubMed |
| Time-Course of Transcriptomic Change in the Lungs of F344 Rats Repeatedly Exposed to a Multiwalled Carbon Nanotube in a 2-Year Test. | Nanomaterials (Basel) | 2023 | 37513116 | PubTator, text mining | PubMed |
| Research progress on post-translational modification of proteins and cardiovascular diseases. | Cell Death Discov | 2023 | 37507372 | PubTator, text mining | PubMed |
| The role of IFN-γ-signalling in response to immune checkpoint blockade therapy. | Essays Biochem | 2023 | 37503572 | PubTator, text mining | PubMed |
| Integrated bioinformatic analysis and experimental validation for exploring the key molecular of brain inflammaging. | Front Immunol | 2023 | 37492566 | PubTator, text mining | PubMed |
| The impact of the apelinergic system in coronary collateral formation. | Turk Gogus Kalp Damar Cerrahisi Derg | 2023 | 37484641 | PubTator, text mining | PubMed |
| Immune function of colon cancer associated miRNA and target genes. | Front Immunol | 2023 | 37465677 | PubTator, text mining | PubMed |
| A qualitative assessment of stakeholder perspectives on barriers and facilitators to emergency care delays in Northern Tanzania through the Three Delays. | Afr J Emerg Med | 2023 | 37456586 | PubTator, text mining | PubMed |
| Cardiovascular aspects of ELABELA: A potential diagnostic biomarker and therapeutic target. | Vascul Pharmacol | 2023 | 37433415 | PubTator, text mining | PubMed |
| Astrocyte-derived complement C3 is activated in patients with tuberous sclerosis complex and mediates immune injury: an integrated bioinformatics analysis. | Transl Pediatr | 2023 | 37427054 | PubTator, text mining | PubMed |
| The role of apelinergic system in metabolism and reproductive system in normal and pathological conditions: an overview. | Front Endocrinol (Lausanne) | 2023 | 37424869 | PubTator, text mining | PubMed |
| Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput platform. | Nat Commun | 2023 | 37407564 | PubTator, text mining | PubMed |
| Atherosclerosis treatment with nanoagent: potential targets, stimulus signals and drug delivery mechanisms. | Front Bioeng Biotechnol | 2023 | 37404681 | PubTator, text mining | PubMed |
| The landscape of cancer rewired GPCR signaling axes. | bioRxiv | 2023 | 37398064 | PubTator, text mining | PubMed |
| The recent progress of peptide regulators for the Wnt/β-catenin signaling pathway. | Front Med (Lausanne) | 2023 | 37396899 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/187/papers?page=14